SCHEMBL1009042

SCHEMBL1009042

CCC(Nc1ccccc1)S(=O)(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.42
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
KEAP1 Q14145 1/20 0.39
ACP1 P24666 2/20 0.38
ALDH1A1 P00352 4/20 0.37
LMNA P02545 3/20 0.37
GAA P10253 2/20 0.37
PKM P14618 1/20 0.37
CYP3A4 P08684 3/20 0.37
ALOX15 P16050 3/20 0.37
TSHR P16473 3/20 0.37
HSD17B10 Q99714 3/20 0.37
THRB P10828 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ALOX12 P18054 2/20 0.37
RECQL P46063 1/20 0.37
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1607865 0.86 SMN1; SMN2 (0.42) TDP1CA12CA9MEN1KMT2A
SCHEMBL1607518 0.83 ALDH1A1 (0.43) CA12CA9MEN1KMT2AALDH1A1
SCHEMBL1606119 0.82 ALDH1A1 (0.49) TDP1CA12CA9KEAP1ACP1
SCHEMBL27617207 0.82 GAA (0.46) MEN1KMT2AALDH1A1LMNAGAA
SCHEMBL9551532 0.80 GAA (0.45) MEN1KMT2AALDH1A1LMNAGAA
SCHEMBL17706031 0.79 TDP1 (0.39) TDP1CA12CA9MEN1KMT2A
SCHEMBL1823997 0.76 HTT (0.46) CA12CA9LMNAGAACYP3A4
SCHEMBL9364727 0.75 LMNA (0.42) TDP1CA12CA9MEN1KMT2A
SCHEMBL1608004 0.75 TDP1 (0.52) TDP1CA12CA9MEN1KMT2A
SCHEMBL5779283 0.74 CYP4F2 (0.45) MEN1KMT2ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2319937-B1 BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD NIPPON KAYAKU KK (JP) 2016-01-27 EP claimed
US-8883439-B2 Blood component measurement method utilizing hemolyzed whole blood, and kit for the method NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-11-11 US claimed
US-8313892-B2 Multi-layer body, method for forming resist pattern, method for manufacturing device having pattern by fine processing and electronic device FUJITSU LIMITED (JP) 2012-11-20 US claimed
US-20110165608-A1 BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-07 US claimed
EP-2319937-A1 BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD Nippon Kayaku Kabushiki Kaisha (JP) 2011-05-11 EP claimed
EP-1470242-A2 ENZYMATIC CYCLING ASSAYS FOR HOMOCYSTEINE AND CYSTATHIONINE Catch, Inc. (US) 2004-10-27 EP claimed
EP-1230381-A4 ENZYMATIC CYCLING ASSAYS FOR HOMOCYSTEINE AND CYSTATHIONINE CATCH INC (US) 2004-10-13 EP claimed
WO-2003040694-A2 ENZYMATIC CYCLING ASSAYS FOR HOMOCYSTEINE AND CYSTATHIONINE CATCH, INC. (US) 2003-05-15 WO claimed
EP-1230381-A2 ENZYMATIC CYCLING ASSAYS FOR HOMOCYSTEINE AND CYSTATHIONINE Catch, Inc. (US) 2002-08-14 EP claimed
WO-2001033187-A2 ENZYMATIC CYCLING ASSAYS FOR HOMOCYSTEINE AND CYSTATHIONINE CATCH, INC. (US) 2001-05-10 WO claimed
US-5439827-A A mixture containing an oxidizer iron ammonium salt complexes eliminating interference of ascorbic acid KYOTO DAIICHI KAGAKU CO., LTD. (JP) 1995-08-08 US claimed
US-12264356-B2 Method for determining sensitivity to SGLT2 inhibitor and sensitivity marker for SGLT2 inhibitor NIHON UNIVERSITY (JP) 2025-04-01 US disclosed
CN-118382704-A Method for reducing measurement error caused by haemoglobin 东洋纺株式会社 2024-07-23 CN disclosed
WO-2023190087-A1 ENHACEMENT OF ACCURACY WHEN MEASURING HIGH-CREATININE-VALUE SPECIMEN 東洋紡株式会社 2023-10-05 WO disclosed
WO-2023191077-A1 METHOD FOR ASSISTING WITH STRATIFICATION OF FRAILTY PROGRESSION LEVEL EVALUATION, STRATIFICATION DEVICE, AND STRATIFICATION PROGRAM 東洋紡株式会社 2023-10-05 WO disclosed
US-5081259-A Novel amino acid substituted 4-aminophenazones for measuring enzyme activity ABBOTT LABORATORIES (US) 1992-01-14 US disclosed
EP-0459255-A2 Method for suppression of electrification HITACHI, LTD. (JP) 1991-12-04 EP disclosed
EP-0136142-B1 THERMALLY DEVELOPABLE, LIGHT-SENSITIVE MATERIAL KONICA CORPORATION (JP) 1990-04-11 EP disclosed
EP-0346870-A2 Novel amino acid substituted 4-aminophenazones for measuring enzyme activity THE BOARD OF GOVERNORS OF WAYNE STATE UNIVERSITY (US) 1989-12-20 EP disclosed
EP-0243901-A1 Process and reagent for the detection of heart lesions or heart diseases Roche Diagnostics GmbH (DE) 1987-11-04 EP disclosed